|
Volumn 24, Issue 1, 2002, Pages 80-84
|
Economic endpoints in clinical trials
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CLINICAL RESEARCH;
CLINICAL TRIAL;
COST EFFECTIVENESS ANALYSIS;
DATA ANALYSIS;
ECONOMICS;
HEALTH CARE COST;
HEALTH CARE UTILIZATION;
HOSPITAL BILLING;
HUMAN;
MATHEMATICAL ANALYSIS;
PRIORITY JOURNAL;
REVIEW;
ARTICLE;
CONTROLLED CLINICAL TRIAL;
COST;
COST BENEFIT ANALYSIS;
HEALTH CARE PLANNING;
RANDOMIZED CONTROLLED TRIAL;
STATISTICAL ANALYSIS;
STATISTICS;
UNITED STATES;
COST-BENEFIT ANALYSIS;
COSTS AND COST ANALYSIS;
DATA INTERPRETATION, STATISTICAL;
HEALTH RESOURCES;
HUMAN;
RANDOMIZED CONTROLLED TRIALS;
UNITED STATES;
HUMANS;
|
EID: 0036019125
PISSN: 0193936X
EISSN: None
Source Type: Journal
DOI: 10.1093/epirev/24.1.80 Document Type: Review |
Times cited : (8)
|
References (16)
|